⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4794828 | 0.96 | — | — | |
| Diethylamine SCHEMBL2724925 | 0.78 | — | — | |
| Diethylamine SCHEMBL27865996 | 0.73 | — | — | |
| Diethylamine SCHEMBL28240786 | 0.73 | — | — | |
| Diethylamine SCHEMBL7368833 | 0.71 | — | — | |
| Diethylamine SCHEMBL3558785 | 0.71 | — | — | |
| Diethylamine SCHEMBL2698 | 0.71 | — | — | |
| Diethylamine SCHEMBL7130457 | 0.71 | TP53 (1.00) | — | |
| Diethylamine SCHEMBL27887418 | 0.70 | — | — | |
| Diethylamine SCHEMBL3520371 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023225089-A1 | PROCESS FOR PRODUCING ALKALI HYDROXIDE OR ALKALINE EARTH OXIDE EMPLOYING A WEAK ACID INTERMEDIATE | Innovator Energy, LLC (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-4220844-A2 | LITHIUM ION BATTERY USING CROSSLINKED SEPARATOR | Asahi Kasei Kabushiki Kaisha (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-4012031-A1 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ALPHA-1 ANTITRYPSIN BY DOUBLE-STRANDED RNA | Dicerna Pharmaceuticals, Inc. (US) | 2022-06-15 | — | — | EP | disclosed |
| US-20200369851-A1 | High Resistivity Rubber Compositions Comporising Oxidized Carbon Bkack | BIRLA CARBON U.S.A., INC. (US) | 2020-11-26 | — | — | US | disclosed |
| US-20190240649-A1 | CATALYST FOR CURABLE COMPOSITIONS CONTAINING HEXAHYDROTRIAZINE STRUCTURAL UNITS | SIKA TECHNOLOGY AG (CH) | 2019-08-08 | — | — | US | disclosed |
| EP-2723719-B1 | PIPERAZINE DERIVATIVES, THEIR PREPARATION PROCESSES AND THEIR USES IN THE TREATMENT OF INSULINORESISTANCE | METABOLYS (FR) | 2016-11-30 | — | — | EP | disclosed |
| US-20160236536-A1 | FUEL CELL VEHICLE AND CONTROL METHOD THEREOF | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2016-08-18 | — | — | US | disclosed |
| US-20160209428-A1 | DIAGNOSTIC AND PREDICTIVE METABOLITE PATTERNS FOR DISORDERS AFFECTING THE BRAIN AND NERVOUS SYSTEM | The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel | 2016-07-21 | — | — | US | disclosed |
| EP-2684562-A1 | Fibre layer with an active substance on the basis of bio-polymers, applications of same and method for their manufacture | BASF SE (DE) | 2014-01-15 | — | — | EP | disclosed |
| EP-2561871-A1 | Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer | The Regents of The University of California (US) | 2013-02-27 | — | — | EP | disclosed |
| EP-2444085-A1 | Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer | The Regents of The University of California (US) | 2012-04-25 | — | — | EP | disclosed |
| EP-1893196-B1 | DIARYLHYDANTOIN COMPOUND | UNIV CALIFORNIA (US) | 2012-01-18 | — | — | EP | disclosed |
| US-7998733-B2 | Chimeric vectors | MERIAL LIMITED (US) | 2011-08-16 | — | — | US | disclosed |
| US-20110076669-A1 | METHODS AND COMPOSITIONS FOR PRESERVING PLATELETS | BIOVEC TRANSFUSION, LLC (US) | 2011-03-31 | — | — | US | disclosed |
| US-20080206252-A1 | Novel Polypeptides, and Nucleic Acids Encoding the Same | GENENTECH, INC. (US) | 2008-08-28 | — | — | US | disclosed |
| EP-1771456-A2 | HYBRID QA MOLECULES WHEREIN Q IS AN AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, THEIR SYNTHESIS AND THEIR USES AS ANTIBACTERIAL AGENT | Palumed SA (FR) | 2007-04-11 | — | — | EP | disclosed |
| WO-2006024741-A2 | HYBRID QA MOLECULES WHEREIN Q IS AN AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, THEIR SYNTHESIS AND THEIR USES AS ANTIBACTERIAL AGENT | PALUMED S.A. (FR) | 2006-03-09 | — | — | WO | disclosed |
| CN-1355713-A | Releasable bond and composition containing the same | ALZA CORP (US) | 2002-06-26 | — | — | CN | disclosed |